Sealant gel approved for eye surgery

(HealthDay)—A sealant gel to prevent fluid leakage after cataract surgery has been approved by the U.S. Food and Drug Administration.

While gels such as ReSure have been approved to seal small incisions in other parts of the body, this is the first such approval for the eye, the agency said in a news release.

A cataract is a gradual clouding of the eye's lens. By age 80, more than half of Americans have either an active cataract or have had , the U.S. National Institutes of Health estimates.

The ReSure Sealant kit includes two liquid solutions that are mixed together just before use. The product is designed to seal an eye incision within 20 seconds of application, the FDA said. The gel then breaks down over seven days and is naturally flushed away by the eye's tears.

No serious to the gel were reported, the FDA said.

Before this approval, stitches were the only option for closing a leaking corneal after cataract surgery, the agency said. The product was evaluated in a clinical study of 471 adults.

The ReSure sealant is produced by Ocular Therapeutix, based in Bedford, Mass.

More information: The U.S. National Library of Medicine has more about cataracts.

add to favorites email to friend print save as pdf

Related Stories

Glaucoma stent approved

Jun 26, 2012

(HealthDay) -- An ocular stent that's designed to reduce inner-eye pressure among people with mild or moderate open-angle glaucoma has been approved by the U.S. Food and Drug Administration.

Smoking cessation reduces risk of cataract extraction

Jan 07, 2014

(HealthDay)—Smoking cessation correlates with a reduction in the risk of cataract extraction, although the risk persists for more than 20 years, according to a study published online Jan. 2 in JAMA Ophthalmology.

Recommended for you

HIV/AIDS drugs could be repurposed to treat AMD

Nov 20, 2014

A landmark study published today in the journal Science by an international group of scientists, led by the laboratory of Dr. Jayakrishna Ambati, professor & vice chair of the Department of Ophthalmology & Visu ...

New laser therapy helps slow macular degeneration

Nov 19, 2014

(Medical Xpress)—A new, low impact low energy laser treatment for patients with early age-related macular degeneration (AMD) has produced positive results by reducing indicators of the disease.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.